COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Teich, V [1 ]
Passos, R. B. F. [1 ]
Vianna, D. [2 ]
机构：
[1] MedInsight, Rio De Janeiro, Brazil
[2] Univ Rio de Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75381-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran (vol 21, pg 282, 2018)
    Amiri, A.
    Goudarzi, R.
    Amiresmaili, M.
    Iranmanesh, F.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (03) : 312 - 312
  • [22] Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban
    van Hooff, Robbert-Jan
    Nieboer, Koenraad
    De Smedt, Ann
    Yperzeele, Laetitia
    Jochmans, Kristin
    De Keyser, Jacques
    Brouns, Raf
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 122 : 133 - 134
  • [23] Cost-effectiveness analysis of tissue plasminogen activator for acute ischemic stroke in National Taiwan University Hospital Hsinchu Branch
    Chou, P.
    Jen, W.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 293 - 293
  • [24] BUDGETARY IMPACT ANALYSIS OF ALTEPLASE RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (RTPA) - AS A THROMBOLYTIC TREATMENT FOR ACUTE ISCHEMIC STROKE IN COLOMBIA
    Lasalvia, P.
    VALUE IN HEALTH, 2022, 25 (07) : S428 - S428
  • [25] COST-EFFECTIVENESS ANALYSIS OF TENECTEPLASE VS ALTEPLASE FOR TREATMENT OF ACUTE ISCHEMIC STROKE
    Dasari, D.
    Deshmukh, A. A.
    VALUE IN HEALTH, 2020, 23 : S268 - S268
  • [26] THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE ISCHEMIC STROKE - EVALUATION WITH RCBF-SPECT
    HERDERSCHEE, D
    LIMBURG, M
    VANROYEN, EA
    HIJDRA, A
    BULLER, HR
    KOSTER, PA
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (05): : 317 - 322
  • [27] Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
    Hong, Keun-Sik
    Park, So-Young
    Whang, Seon-Il
    Seo, So-Young
    Lee, Dong-Ha
    Kim, Han-Joon
    Cho, Joong-Yang
    Cho, Yong-Jin
    Jang, Woo-Ik
    Kim, Chang Young
    JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (01): : 49 - 52
  • [28] Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France
    Kabore, N.
    Marnat, G.
    Rouanet, F.
    Barreau, X.
    Verpillot, E.
    Menegon, P.
    Maachi, I
    Berge, J.
    Sibon, I
    Benard, A.
    REVUE NEUROLOGIQUE, 2019, 175 (04) : 252 - 260
  • [29] Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI
    Schellinger, PD
    Jansen, O
    Fiebach, JB
    Heiland, S
    Steiner, T
    Schwab, SF
    Pohlers, O
    Ryssel, H
    Sartor, K
    Hacke, W
    STROKE, 2000, 31 (06) : 1318 - 1328
  • [30] Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Response
    Toyoda, Kazunori
    Koga, Masatoshi
    Minematsu, Kazuo
    STROKE, 2010, 41 (03) : E165 - E165
12345